The present subgroup analysis of KEYNOTE-062 suggests that the proportion of patients enrolled in Asia with tumours that were MSI-H and PD-L1 CPS ≥1 (3.3%–6.5%) was comparable with the overall study population (5.5%–7.6%) (14). This evidence concerns the gene CD274 and neoplasm.